Evidence map›Paper›PMID 30995806›Full record

ReviewInternational journal of molecular sciences2019

Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases.

Barbara Ruder, Raja Atreya, Christoph Becker

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 2 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 2 syntheses or guidelines pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Barbara RuderDepartment of Medicine 1, University of Erlangen-Nürnberg, Hartmannstr. 14, D-91052 Erlangen, Germany. Barbara.Ruder@uk-erlangen.de.
Raja AtreyaDepartment of Medicine 1, University of Erlangen-Nürnberg, Hartmannstr. 14, D-91052 Erlangen, Germany. Raja.Atreya@uk-erlangen.de.
Christoph BeckerDepartment of Medicine 1, University of Erlangen-Nürnberg, Hartmannstr. 14, D-91052 Erlangen, Germany. Christoph.Becker@uk-erlangen.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

Deutsche Forschungsgemeinschaft FOR 2886 (A02)Deutsche Forschungsgemeinschaft Heisenberg professorshipDeutsche Forschungsgemeinschaft SFB1181 (C05, A08, C02)Deutsche Forschungsgemeinschaft SFB796 (B09)Deutsche Forschungsgemeinschaft SPP1656Deutsche Forschungsgemeinschaft TRR241 (A02, A03, C02, INF)Interdisziplinäres Zentrum für klinische Forschung Universitär Erlangen-Nürnberg IZKF (A75)
6 · The paper itself

Abstract

The intestinal epithelium constitutes an indispensable single-layered barrier to protect the body from invading pathogens, antigens or toxins. At the same time, beneficial nutrients and water have to be absorbed by the epithelium. To prevent development of intestinal inflammation or tumour formation, intestinal homeostasis has to be tightly controlled and therefore a strict balance between cell death and proliferation has to be maintained. The proinflammatory cytokine tumour necrosis factor alpha (TNFα) was shown to play a striking role for the regulation of this balance in the gut. Depending on the cellular conditions, on the one hand TNFα is able to mediate cell survival by activating NFκB signalling. On the other hand, TNFα might trigger cell death, in particular caspase-dependent apoptosis but also caspase-independent programmed necrosis. By regulating these cell death and survival mechanisms, TNFα exerts a variety of beneficial functions in the intestine. However, TNFα signalling is also supposed to play a critical role for the pathogenesis of inflammatory bowel disease (IBD), infectious diseases, intestinal wound healing and tumour formation. Here we review the literature about the physiological and pathophysiological role of TNFα signalling for the maintenance of intestinal homeostasis and the benefits and difficulties of anti-TNFα treatment during IBD.

Indexed as

HomeostasisAnimalsAntibodiesBacterial InfectionsDrug DiscoveryGastrointestinal DiseasesHumansInflammatory Bowel DiseasesIntestinal MucosaIntestinesTumor Necrosis Factor-alphaVirus DiseasesAntibodiesTumor Necrosis Factor-alphaanti-TNFα treatmentcell deathIBDinfectious diseaseintestinal epitheliumtumour necrosis factor

Identifiers

PMID30995806
PMCPMC6515381
OpenAlexW2937016415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.